Back
Windtree Therapeutics Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
27
WINT
Windtree Therapeutics
Last Price:
0.49
Seasonality Move:
-4.03%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing selling pressure, which indicates risk of future bearish movement.
Windtree Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.61 | Sell |
| 20-day SMA: | 0.75 | Sell |
| 50-day SMA: | 1.69 | Sell |
| 200-day SMA: | 4.93 | Sell |
| 8-day EMA: | 0.61 | Sell |
| 20-day EMA: | 0.84 | Sell |
| 50-day EMA: | 2.07 | Sell |
| 200-day EMA: | 11.4 | Sell |
Windtree Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 26.02 | Sell |
| Chaikin Money Flow: | -363752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.61 - 0.87) | Sell |
| Bollinger Bands (100): | (0.61 - 7.97) | Sell |
Windtree Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Windtree Therapeutics Stock
Is Windtree Therapeutics Stock a Buy?
- Windtree Therapeutics share price is 0.53 while WINT 8-day simple moving average is 0.61, which is a Sell signal.
- The stock price of WINT is 0.53 while Windtree Therapeutics 20-day SMA is 0.75, which makes it a Sell.
- Windtree Therapeutics 50-day simple moving average is 1.69 while WINT share price is 0.53, making it a Sell technically.
- WINT stock price is 0.53 and Windtree Therapeutics 200-day simple moving average is 4.93, creating a Sell signal.
WINT Technical Analysis vs Fundamental Analysis
Sell
27
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy or a Sell?
-
Windtree Therapeutics stock is rated a Sell
The current Windtree Therapeutics [WINT] share price is $0.53. The Score for WINT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Windtree Therapeutics Stock Info
Market Cap:
312.3K
Price in USD:
0.53
Share Volume:
375.49K
Windtree Therapeutics 52-Week Range
52-Week High:
22.36
52-Week Low:
0.53
Sell
27
Windtree Therapeutics (WINT)
is a Sell
Windtree Therapeutics Share Price Forecast
-
What is the Windtree Therapeutics stock price today?
The Windtree Therapeutics stock price is 0.53 USD today. -
Will WINT stock go up or go down?
Windtree Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Windtree Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Windtree Therapeutics is overvalued.
Is Windtree Therapeutics Stock a Buy?
- Windtree Therapeutics share price is 0.53 while WINT 8-day exponential moving average is 0.61, which is a Sell signal.
- The stock price of WINT is 0.53 while Windtree Therapeutics 20-day EMA is 0.84, which makes it a Sell.
- Windtree Therapeutics 50-day exponential moving average is 2.07 while WINT share price is 0.53, making it a Sell technically.
- WINT stock price is 0.53 and Windtree Therapeutics 200-day simple moving average is 11.40, creating a Sell signal.
Fundamental Analysis of Windtree Therapeutics
Is Windtree Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $92.48 per share, and an increase next year of $0.25 per share.
Technical Analysis of Windtree Therapeutics
Should I short Windtree Therapeutics stock?
- WINT Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Windtree Therapeutics is a Sell
- Windtree Therapeutics Relative Strength Index (RSI) is 26.02, which suggest Windtree Therapeutics is oversold
- The Bollinger Bands (25) for Windtree Therapeutics is (0.61 - 0.87), which suggest Windtree Therapeutics is a Sell
- The Bollinger Bands (100) for Windtree Therapeutics is (0.61 - 7.97), which suggest Windtree Therapeutics is a Sell
* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.